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Abstract : Magnetic resonance imaging （MRI） is an important means of evaluating 
local extension of endometrial cancer.  The 3.0 Tesla （T） MRI system introduced 
in 2005 improved the diagnostic capabilities of this modality due to an increased 
signal to noise ratio ; however, it was also susceptible to artifacts and debate 
remains regarding the clinical applicability of 3.0 T MRI in the pelvic region. A 
few reports have compared 1.5 T and 3.0 T MRI for determining the degree of 
progression of endometrial cancer.  Therefore, we conducted a comparative study of 
the diagnostic capability of 1.5 T and 3.0 T MRI for the local extension of endo-
metrial cancer.  Over the 6 years and 8 months from 1 January 2008 to 30 August 
2014, preoperative MRI has been conducted at our hospital including T2-weighted 
imaging, diffusion-weighted imaging, and dynamic contrast-enhanced MRI for cases 
of endometrioid adenocarcinoma requiring surgery.  We investigated 60 subjects 
after excluding cases for which the tumor could not be imaged and cases that 
underwent surgery 2 months or more after undergoing MRI.  Two radiologists used 
magnetic resonance images taken preoperatively to determine local extension using 
T2-weighted, diffusion-weighted, and dynamic-study images.  Results for local exten-
sion were compared with those of postoperative histopathology.  Results indicated 
no signicant difference in accurate diagnosis rates between 1.5 T and 3.0 T MRI 
for any of the imaging modalities examined by both radiologists.
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Introduction
　As of 2013, endometrial cancer was the seventh most common site-specic cause of mortality 
in women in Japan 1）. Most cases of endometrial cancer are adenocarcinoma, with endometrioid 
adenocarcinoma the most prevalent. Statistics from the Japan Society of Obstetrics and Gyn-
aecology in 2009 indicated that more than 80％ of malignant tumours of the uterine body are 
endometrioid adenocarcinomas2）.
　The degree of histological differentiation and myometrial inltration correlate with prognosis, 
prompting the International Federation of Gynaecology and Obstetrics （FIGO） to take these 
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factors into account in recommending a surgical staging system.  In Japan, rules for handling 
endometrial cancer have been established based on these FIGO classications and TNM clas-
sication.
　Diagnostic imaging plays an important role in the initial staging, which is essential for deter-
mining treatment strategy.  Until recently, magnetic resonance imaging （MRI） was an important 
method of preoperative evaluation for endometrial cancer, used in assessing the depth of myo-
metrial invasion.  Contrast-enhanced MRI is superior to non-contrast-enhanced MRI, computed 
tomography （CT）, and ultrasound imaging for evaluating myometrial and cervical inltration 3-6）.
　In recent years, the use of 3.0 Tesla （T） MRI, which uses a strong magnetic eld （two times 
stronger than that of 1.5 T MRI）, has spread rapidly and 3.0 T MRI is being clinically applied 
in various elds.  Compared to 1.5 T systems, the 3.0 T system offers increased signal to noise 
ratio （SNR）, magnetic susceptibility, chemical shift, and specic absorption rate （SAR）, with the 
increased SNR constituting a signicant advantage.  However, as magnetic susceptibility effects 
are proportional to static magnetic eld intensity, their enhancement with 3.0 T MRI intrduces 
new artifacts and distortion.  Increased chemical shift also leads to prominent chemical shift 
artects.  Thus, 3.0 T MRI offers both advantages and disadvantages for diagnostic imaging and 
its superiority for diagnosis in the abdominal and pelvic regions has not been sufciently proven. 
　Thus far, few studies have compared 1.5 T and 3.0 T MRI diagnosis of local extension in 
endometrial cancer 6-8）, thus we undertook such a comparative study in cases of endometrioid 
adenocarcinoma. 
Materials and methods
　Ethics approval for this retrospective study was granted by the institutional review board, and 
patient consent was not required.
　Subjects comprised endometrioid adenocarcinoma patients diagnosed with endometrial cancer 
via MRI who underwent a surgical procedure within 2 months from diagnosis during the period 
from 1 January 2008 to 30 August 2014. None of the selected patients had a history of uterine 
surgery including caesarean section.
　Eligible MRI tests were T2-weighted axial views, diffusion-weighted images and dynamic con-
trast-enhanced imaging. A total of 59 patients （mean age : 58.67 years, range : 33-92 years） were 
registered for this study, all of whom had not undergone chemotherapy or radiation therapy 
prior to the surgical procedure.
　Selection of MRI equipment was randomly determined without consultation of the radiologist 
or gynaecologist.
MRI Testing
　The 59 patients underwent testing using a body coil MRI system （SIEMENS Ltd.）; of these, 
37 patients underwent imaging with 3.0 T MRI （Magnetom Trio A Tim 3.0T, SIEMENS）, 18 
underwent imaging with 1.5 T MRI （Magnetom Avanto 1.5T, SIEMENS）, and 4 patients under-
went imaging with 1.5 T MRI （Magnetom ESSENZA 1.5T, SIEMENS）.  All patients underwent 
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MRI before undergoing surgery, and compression bands were used in every patient to reduce 
motion artefact.
　Spin echo T2-weighted axial view images were taken perpendicular to the endometrial body 
and the scan parameters were as follows : TR/TE, 6000-4500/103-94 msec; slice thickness, 5 mm ; 
eld of view （FOV）, 22 cm ; matrix, 384 × 307 （3.0 T）, 384 × 269 （1.5 T）.  Spin echo T2-weight-
ed sagittal view images were taken parallel to the endometrial body and the scan parameters 
were as follows : TR/TE, 4000-6000/91-112 msec ; slice thickness, 5 mm ; FOV, 19.4-26 cm ; matrix, 
320 × 242（3.0 T）, 320 × 256 （1.5 T）.
　Diffusion-weighted images were taken perpendicular to the body axis and the scan param-
eters were as follows : TR/TE, 4500-3100/97-77 msec ; slice thickness, 3-5 mm ; FOV, 17.5-27.3 ×
35-40 cm ; matrix size, 128 × 72 （3.0 T）, 128 × 72 （1.5 T）; b-values, 50, 500, 1000 and 2000 s/mm2 
imaging （sensitivity encoding ［SENSE］）, and a refocusing ip angle.
　Dynamic contrast-enhanced images were performed with volumetric interpolated breath-hold 
sampling （VIBE） in 56 cases and fast low-angle shot （FLASH） was performed for 3 cases, in 
accordance with the following sequence : 1） VIBE ; TR/TE, 3.2-7.8/1.24-4.76 msec ; slice thickness, 
2.5-5 mm ; FOV, 25-30 cm ; matrix size, 288-448 × 268-259 （3.0 T）, 256-320 × 224-228 （1.5 T）, 2） 
FLASH ; TR/TE, 160-200/2.46 msec; slice thickness, 3-5 mm ; FOV, 23-30 cm ; matrix size, 256-
320 × 224-262 （3.0 T）.  In the dynamic contrast-enhanced study, images were acquired at differ-
ent phases relative to the IV injection of gadolinium contrast agent （0.2 ml/kg）: before and 30 
seconds and 120 seconds after intravenous administration of intaravenous contrast. 
Imaging analysis
　On T2-weighted images, tumors exhibited stronger signal intensity than normal myometrium 
and lower signal intensity than normal endometrium.  On diffusion-weighted images, tumors 
exhibited higher signal intensity than normal myometrium and lower signal intensity than the 
ADC （apparent diffusion coefciennt map）.  In the dynamic-contrast images, tumors were ren-
dered as areas with less contrast than normal myometrium.
　Local extension diagnosis was evaluated using T2-weighted axial and sagittal view images, 
diffusion-weighted images, and dynamic contrasted images.  Two physicians （each with 4 years of 
experience in diagnostic imaging） independently determined local tumor extension using UICC 
version 7 and TNM classications.  We compared their results for T classication on the three 
MRI types, and then investigated consistency between each patient’s histopathological results and 
the MRI-diagnosed local extension.
　SPSS version 17.0 was used for statistical analysis, together with the chi-squared test.  A 
P-value＜ 0.05 was considered statistically signicant.
Results
　Of the 59 patients, 42 were classied as T1a, 11 as T1b, 4 as T2, 1 as T3a, and 1 as T3b. 
　According to radiologist 1, the accurate diagnosis rates were 18/22, 20/22, and 20/22 for 1.5 
T and 32/37, 35/37, and 33/37 for 3.0 T from the T2-weighted, diffusion-weighted, and dynamic 
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contrasted images, respectively, with no signicant difference found （P＝ 0.833, 0.586, and 0.833）. 
These results are presented in Tables 1.
　According to Radiologist 2, the accurate diagnosis rate was 16/22, 18/22, and 18/22 for 1.5 
T and 29/37, 29/37, and 33/37 for 3.0 T from the T2-weighted, diffusion-weighted, and dynamic 
contrasted images, respectively, with no signicant difference found （P＝ 0.622, 0.921, and 0.424）. 
These results are presented in Tables 2.
　The signicant difference of the accurate diagnosis rate of the stage progress was not recog-
nized by Radiologist 1 （Table 3-5）.
　The signicant difference of the accurate diagnosis rate of the stage progress was not also 
recognized by Radiologist 2 （Table 6-8）.
　Analysis using the chi-squared test indicated no signicant difference between T-factor deter-
mination with 1.5 T and 3.0 T MRI and the κ -statistics indicated a good degree of agreement 
between the two observers （κ＝ 0.64）.
Discussion
　Diagnostic imaging plays an important role in initial staging of tumors, which is essential for 
determining treatment strategy.  MRI T2-weighted images are mainly used to evaluate local 
extension of endometrial cancer.  However, accurate evaluation is difficult with T2-weighted 
images alone, and often contrast-enhanced MRI is necessary.  The European Society for Uro-
logical Research recommends using T2-weighted images in combination with dynamic contrast-
enhanced images for endometrial cancer staging and it has been reported in the past that this 
combination can increase the accurate diagnosis rate for myometrial inltration 9）.
　The higher SNR of 3.0 T MRI was expected to improve the diagnostic capability and its 
superiority for angiography, contrast-enhanced T1-weighted imaging, imaging bony and soft 
regions, and coronary angiography during respiratory arrest 10-17）.  Although 3.0 T MRI offers a 
high SNR （Fig 1, 2）, problems associated with it in comparison to 1.5 T MRI are inferior high 
frequency uniformity, different organ and tissue relaxation time, tendency for high SAR, high 
chemical shift, and strong magnetic susceptibility ; all of which could potentially erode image 
quality.  Accordingly, another disadvantage of 3.0 T MRI is susceptibility to artifacts in the 
abdominal region and the clinical usefulness of 3.0 T MRI in the pelvic region 10）.
　In this study, we found no difference in superiority between 3.0 T and 1.5 T MRI on 
T2-weighted images, diffusion-weighted images, or contrast-enhanced dynamic images for deter-
mining myometrial inltration, and both systems offered comparable diagnostic capability.  These 
results are consistent with those of past studies6, 7）.  In routine clinical practice, the validity of 
using 3.0T MRI for diagnosing the degree of inltration of endometrial cancer appears to have 
been proven.  Moreover, intestinal peristalsis depressants were used in all of the studies report-
ing the usefulness of 3.0 T MRI 7, 8）.  As we do not use peristalsis inhibitors at our hospital, a 
compression band was used in every patient to reduce motion artifacts.  Thus one limitation of 
this study is the lack of comparison between patients with and without peristalsis depressants. 
However, it has also been suggested that 3.0 T MRI may offer the same diagnostic capability as 
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1.5 T MRI even without peristalsis depressants.
　This study had a number of other limitations.  First, the same patients did not undergo both 
1.5 T and 3.0 T MRI so comparisons could not be made between the results for each patient. 
It is not benecial for patients to undertake an MRI examination twice, because of the extra 
cost and possibility of adverse reaction to the contrast agent.  Accordingly, results only indicate 
no signicant difference in diagnostic capability of local extension of endometrial cancer in a 
population using 1.5 T and 3.0 T MRI and do not indicate differences for individual cases. 
Second, T2-weighted images were taken in sagittal and axial views, whereas diffusion-weighted 
Table 1.  Accurate diagnosis rate assessment for 
Radiologist 1
MRI  
（n＝ 59）
1.5 T  
（n＝ 22）
3.0 T  
（n＝ 37） P-value
T2WI 18/22 32/37 0.833
DWI 20/22 35/37 0.586
Dynamic study 20/22 33/37 0.622
Table 3.  Radiologist 1 - accurate diagnosis rate for 
pT1a vs. pT1b cases with T2WI
Diagnosis  
（n＝ 53）
1.5 T  
（n＝ 19）
3.0 T  
（n＝ 34） P-value
 pT1a （n＝ 42） 14/16 24/26 0.558
PT1b （n＝ 11） 3/3 7/8 0.521
Table 5.  Radiologist 1 - accurate diagnosis rate for 
pT1a vs. pT1b cases with dynamic contrast 
imaging
Diagnosis  
（n＝ 53）
1.5 T  
（n＝ 19）
3.0 T  
（n＝ 34） P-value
 pT1a （n＝ 42） 16/16 25/26 0.442
PT1b （n＝ 11） 3/3 7/8 0.521
Table 7.  Radiologist 2 - accurate diagnosis rate for 
pT1a vs. pT1b cases with DWI
Diagnosis  
（n＝ 53）
1.5 T  
（n＝ 19）
3.0 T  
（n＝ 34） P-value
 pT1a （n＝ 42） 13/16 23/26 0.460
PT1b （n＝ 11） 3/3 5/8 0.214
Table 8.  Radiologist 2 - accurate diagnosis rate for 
pT1a vs. pT1b cases with dynamic study
Diagnosis  
（n＝ 53）
1.5 T  
（n＝ 19）
3.0 T  
（n＝ 34） P-value
 pT1a （n＝ 42） 13/16 25/26 0.110
PT1b （n＝ 11） 3/3 5/8 0.214
Table 6.  Radiologist 2 - accurate diagnosis rate for 
pT1a vs. pT1b cases with T2WI
Diagnosis  
（n＝ 53）
1.5 T  
（n＝ 19）
3.0 T  
（n＝ 34） P-value
 pT1a （n＝ 42） 12/16 23/26 0.215
PT1b （n＝ 11） 3/3 4/8 0.125
Table 4.  Radiologist 1 - accurate diagnosis rate for 
pT1a vs. pT1b cases with DWI
Diagnosis  
（n＝ 53）
1.5 T  
（n＝ 19）
3.0 T  
（n＝ 34） P-value
 pT1a （n＝ 42） 16/16 26/26 -
PT1b （n＝ 11） 3/3 8/8 -
Table 2.  Accurate diagnosis rate assessment for 
Radiologist 2
MRI  
（n＝ 59）
1.5 T  
（n＝ 22）
3.0 T  
（n＝ 37） P-value
T2WI 16/22 29/37 0.622
DWI 17/22 29/37 0.921
Dynamic study 18/22 33/37 0.424
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images were only taken in the axial view.  Therefore, evaluation of vertical tumor extension was 
limited with diffusion-weighted images.  Third, the dynamic contrast-enhanced MRI was only 
taken in one direction ; however, we do not believe this was a signicant problem as this imag-
ing direction was determined to be the optimal direction for determining local inltration by the 
radiologist during testing.  Finally, a detailed background of each patient, including risk factors 
of endometrial cancer and medical histories is not included in this study, and it is possible that 
a patient’s background might inuence the evaluation of MR images.  However, no cases of 
previous uterine surgery such as caesarian section were included in this study and the inuence 
of MRI diagnosis on the local invasion of the tumor could be minimized between the cases 
performed with 1.5 T MRI and 3.0 T MRI.
　Recently, multi-channel RF transmitter MRI has been introduced as a means of compensating 
Fig. 1.  A 33-year-old woman diagnosed with pT1b carcinoma （1.5 T MR images）
a. T2-weighted sagittal image, b. T2-weighted axial image, c. Diffusion-weighted axial image,  
d. Dynamic contrast images with 1.5 T MRI.
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for the disadvantages of 3.0 T MRI, and RF uniformity has increased dramatically.  This technol-
ogy has made it possible to acquire images utilizing the 3.0 T MRI characteristic of high SNR. 
Thus, expectations remain high for the future of MRI technology 18）.
　In conclusion, no signicant difference was observed between 3.0 T and 1.5 T MRI in the 
diagnostic capability for evaluating the local extension of endometrial cancer.  This suggests 
strong possibilities for MRI diagnosis in the future with superior time and spatial resolution 
utilizing the high 3.0 T MRI SNR.
Fig. 2.  A 53-year-old woman with pT1b carcinoma （3.0 T MR images）
a. T2-weighted sagittal image, b. T2-weighted axial image, c. Diffusion-weighted axial image,  
d. Dynamic contrast images with 3.0 T MRI; ＊＝ tumor.
T2-weighted sagittal images and axial images, diffusion-weighted images and dynamic contrast 
images are shown with 1.5 T （Fig. 1） and 3.0 T MRI （Fig. 2）.
Images of 3.0 T MRI show higher S/N compared with those of 1.5T, although no difference 
is seen for determining the myometrial infiltration between 3.0 T and 1.5 T MRI.
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